Skip to content

Ayurvedic medication in the treatment of diabetic polyneuropathy

Efficacy of vangeshwara rasa in diabetic polyneuropathy A randomsied controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048743
Enrollment
40
Registered
2023-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G63- Polyneuropathy in diseases classified elsewhere

Interventions

None listed

Sponsors

DR BHANU KUMAR PANCHAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Type 2 Diabetes on Standard anti-diabetic care symptomatic Diabetic Polyneuropathy Patients fulfilling the diagnostic criteria of irrespective of sex religion and socioeconomic status aged between 30-70 years

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Patients with other complications of DM such as Nephropathy Retinopathy and Vasculopathy Patients with recent history of Major CVA Potentially fatal diseases Psychiatric Patients Patients with other metabolic and endocrinal disorders Patients with other causes of Neuropathy Patients with wounds or ulcers

Design outcomes

Primary

MeasureTime frame
Vangeshwara rasa is proven to be effective in Diabetes Polyneuropathy on basis of vibration perception thershold in 45 daysTimepoint: baseline 15th 30th 45th days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDR SUKETHA KUMARI

KAHER SHRI BMK AYURVEDA MAHAVIDHYALAYA BELAGAVI

sukethashetty411@gmail.com9483637757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026